Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Neovascular Membrane”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Testing effectiveness (Phase 2)Study completedNCT00304954
What this trial is testing

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
National Eye Institute (NEI) 13
Not applicableUnknownNCT05055973
What this trial is testing

OCTA Insights in CNVM, Morphological Characteristics and Correlation With Structural OCT.

Who this might be right for
Choroidal Neovascularization
Assiut University 80
Not applicableUnknownNCT05562336
What this trial is testing

Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).

Who this might be right for
Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
Sohag University 2
Testing effectiveness (Phase 2)Ended earlyNCT01025232
What this trial is testing

Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more
David M. Brown, M.D. 88
Large-scale testing (Phase 3)UnknownNCT00370539
What this trial is testing

Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Shahid Beheshti University of Medical Sciences
Post-approval studies (Phase 4)Study completedNCT01453920
What this trial is testing

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 44
Not applicableStudy completedNCT01712035
What this trial is testing

Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Oregon Health and Science University 44
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Post-approval studies (Phase 4)Study completedNCT01863199
What this trial is testing

Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Retinal Consultants of Arizona 60
Large-scale testing (Phase 3)UnknownNCT02727881
What this trial is testing

Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ohr Pharmaceutical Inc. 230
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00021736
What this trial is testing

Phase II/III Study of Anti-VEGF in Neovascular AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Eyetech Pharmaceuticals 540
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Testing effectiveness (Phase 2)Study completedNCT01175395
What this trial is testing

20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
University of Illinois at Chicago 10
Not applicableWithdrawnNCT01218230
What this trial is testing

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

Who this might be right for
Myopic Choroidal Neovascular Membrane
L.V. Prasad Eye Institute
Large-scale testing (Phase 3)UnknownNCT00370370
What this trial is testing

Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Shahid Beheshti University of Medical Sciences
Large-scale testing (Phase 3)Study completedNCT00967850
What this trial is testing

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

Who this might be right for
MyopiaChoroidal Neovascularization
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 56
Post-approval studies (Phase 4)UnknownNCT02033018
What this trial is testing

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

Who this might be right for
Choroidal Retinal Neovascularization
Instituto de Olhos de Goiania 20
Early research (Phase 1)Study completedNCT01024998
What this trial is testing

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationAge-Related MaculopathiesAge-Related Maculopathy+7 more
Genzyme, a Sanofi Company 19
Not applicableNot Yet RecruitingNCT05507840
What this trial is testing

Photobiomodulation for Dry Age Related Macula Degeneration

Who this might be right for
PhotobiomodulationAge-Related Macular Degeneration
Oslo University Hospital 121
Load More Results